Advances in autosomal dominant polycystic kidney disease--2014 and beyond

Autosomal dominant polycystic kidney disease (ADPKD), which frequently leads to end-stage renal disease, currently has no specific drug therapies. Better understanding of its pathogenesis and recent clinical trials have led to more accurate diagnosis of the disease and its manifestations, as well as to promising new approaches to treatment.

Source: Cleveland Clinic Journal of Medicine - September 2, 2014 Category: Journals (General) Authors: BRAUN, W. E. Tags: Medical Grand Rounds Source Type: research